Clinical Trial Update: Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating oxaliplatin for newly diagnosed glioblastoma multiforme has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Glioblastoma
• Glioblastoma Multiforme
• Gliosarcoma

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1, Phase 2 | Status: TERMINATED